# Growth Performance and Intestinal Health of Triploid Rainbow Trout (Oncorhynchus mykiss) Through Bile Acid Supplementation in Low Fishmeal Diets: Insights From Metabolomics, Microbiota, and Gene Expression

**Authors:** Huamin Wang, Siyuan Liu, Zhenhua Ma, Shidi Wang, Shuze Zhang, Shaoxia Lu, Shicheng Han, Haibo Jiang, Gefeng Xu, Hongbai Liu, Chang’an Wang

PMC · DOI: 10.1155/anu/8260382 · 2026-03-05

## TL;DR

Adding 0.10% bile acid to low fishmeal diets improves growth and gut health in triploid rainbow trout.

## Contribution

Demonstrates how bile acid supplementation enhances growth and intestinal health in trout on low fishmeal diets.

## Key findings

- 0.10% bile acid improved final body weight, growth rate, and condition factor in trout.
- Bile acid reduced intestinal inflammation and improved lipid metabolism gene expression.
- Microbial composition and metabolic pathways were significantly altered by bile acid supplementation.

## Abstract

This research aimed to explore the impact of bile acid (BA) supplementation in low fishmeal diets on growth performance, serum biochemical indices, tissue morphology, lipid metabolism, gene expression, and gut microbiota in triploid rainbow trout (Oncorhynchus mykiss, initial weight 15.97 ± 1.4 g). The experimental design involved a low fishmeal diet (10%), and four treatment groups with BA additions (0.05%, 0.10%, 0.15%, and 0.20%) to the basal diet. The findings indicated that the group receiving 0.10% BA (G3) exhibited an enhancement in final body weight (FBW), specific growth rate (SGR), weight gain rate (WGR), and condition factor (CF), significantly outperforming the control group (G1, p < 0.05). 0.10% BA addition significantly increased whole‐body crude protein and lipid content. (p < 0.05). Serum analysis showed a significant reduction in total bilirubin (TBIL) and triglycerides (TG), and an increase in BA and lipoprotein cholesterol (LDL‐C) in the G3 group compared to G1 (p < 0.05). The 0.10% BA supplementation downregulated pro‐inflammatory gene expression, like il-1β, and upregulated lipid metabolism‐related genes, like scdb, in the intestinal tract of O. mykiss (p < 0.05). 16S high‐throughput sequencing identified key microbial groups in the intestine of O. mykiss, highlighting significant differences in microbial composition with BA supplementation. Metabolomic analysis revealed that BA addition altered the metabolic profile of O. mykiss, affecting pathways such as polycyclic aromatic hydrocarbon (PAH) catabolism, cysteine (Cys) and methionine (Met) metabolism, the sulfur relay system, arachidonic acid (AA) metabolism, and ovarian steroidogenesis. In summary, a 0.10% BA addition to the diet of O. mykiss significantly improved growth performance, mitigated intestinal inflammation in specimens fed low fishmeal diets, and promoted overall gut health and lipid metabolism.

## Linked entities

- **Genes:** IL1B (interleukin 1 beta) [NCBI Gene 3553], scdb (stearoyl-CoA desaturase b) [NCBI Gene 553734]
- **Chemicals:** bile acid (PubChem CID 439520), cysteine (PubChem CID 594), methionine (PubChem CID 876), arachidonic acid (PubChem CID 444899)
- **Species:** Oncorhynchus mykiss (taxon 8022)

## Full-text entities

- **Genes:** PPARalpha [NCBI Gene 100505415], FXR [NCBI Gene 101268902], PPIG (peptidylprolyl isomerase G) [NCBI Gene 9360] {aka CARS-Cyp, CYP, SCAF10, SRCyp}, il-8 [NCBI Gene 100136039], il-1beta [NCBI Gene 100136024], il-6 [NCBI Gene 100136689], occludin [NCBI Gene 100462976], actb (actin beta) [NCBI Gene 100135845] {aka B-actin, beta-actin}, il-10 [NCBI Gene 100136835], tnf [NCBI Gene 100136064], vitamin D receptor [NCBI Gene 100136219], COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, pregnane X receptor [NCBI Gene 100136707], LOX (lysyl oxidase) [NCBI Gene 4015] {aka AAT10}, LDL receptor [NCBI Gene 100136009]
- **Diseases:** inflammation (MESH:D007249), pancreas (MESH:D010190), developmental abnormalities (MESH:D006130), cancer (MESH:D009369), cholestasis (MESH:D002779), hypertrophy (MESH:D006984), pancreatic hyperactivity (MESH:D010195), atrophy (MESH:D001284), toxicity (MESH:D064420), inflammatory bowel disease (MESH:D015212), weight gain (MESH:D015430), pathological abnormalities (MESH:D005598), liver damage (MESH:D056486), intestinal and liver damage (MESH:D007410), hyperplasia (MESH:D006965)
- **Chemicals:** NaCl (MESH:D012965), deoxycholic acid (MESH:D003840), hydrogen sulfide (MESH:D006862), BA (MESH:D001647), sulfur (MESH:D013455), Pro (MESH:D011392), phytates (MESH:D010833), Lle (-), Met (MESH:D008715), hematoxylin (MESH:D006416), oxygen (MESH:D010100), TC (MESH:D013667), dihydrodiols (MESH:C507866), unsaturated fatty acid (MESH:D005231), sugar (MESH:D000073893), MDA (MESH:D015104), amino acid (MESH:D000596), nitrogen (MESH:D009584), soy isoflavones (MESH:D007529), prostaglandins (MESH:D011453), His (MESH:D006639), TBIL (MESH:D001663), omega-3 fatty acids (MESH:D015525), nicotinic acid (MESH:D009525), Na2SeO3 (MESH:D018038), xylene (MESH:D014992), hyodeoxycholic acid (MESH:C010471), Asp (MESH:D001224), Ala (MESH:D000409), Arg (MESH:D001120), fatty acid (MESH:D005227), carbohydrate (MESH:D002241), cholic acid (MESH:D019826), Phe (MESH:D010649), CDCA (MESH:D002635), lithocholic acid (MESH:D008095), TG (MESH:D014280), TCA (MESH:D014238), UDCA (MESH:D014580), Val (MESH:D014633), steroid hormones (MESH:D013256), prebiotics (MESH:D056692), glutathione (MESH:D005978), free radicals (MESH:D005609), water (MESH:D014867), calcium pantothenate (MESH:D010205), Tyr (MESH:D014443), sphingosine 1-phosphate (MESH:C060506), Leu (MESH:D007930), petroleum ether (MESH:C004544), taurocholate (MESH:D013656), HF (MESH:D006195), TRIzol (MESH:C411644), KI (MESH:C066186), AA (MESH:D016718), Lipid (MESH:D008055), Cys (MESH:D003545), Glu (MESH:D018698), H. (MESH:D006859), epoxides (MESH:D004852)
- **Species:** Bacteroidota (Bacteroides-Cytophaga-Flexibacter group, phylum) [taxon 976], Micropterus salmoides (largemouth bass, species) [taxon 27706], Oreochromis niloticus (Nile tilapia, species) [taxon 8128], Epinephelus lanceolatus (brindlebass, species) [taxon 310571], Glycine max (soybean, species) [taxon 3847], Vibrio (genus) [taxon 662], Edwardsiella (genus) [taxon 132406], Coprococcus (genus) [taxon 33042], Oncorhynchus mykiss (rainbow trout, species) [taxon 8022], Homo sapiens (human, species) [taxon 9606], Scophthalmus maximus (turbot, species) [taxon 52904], Salmo salar (Atlantic salmon, species) [taxon 8030], Clostridium (genus) [taxon 1485], Acidobacteriota (phylum) [taxon 57723], Ctenopharyngodon idella (grass carp, species) [taxon 7959], Aeromonas salmonicida subsp. achromogenes (subspecies) [taxon 113288], Larimichthys crocea (croceine croaker, species) [taxon 215358], Bos taurus (bovine, species) [taxon 9913], Tachysurus fulvidraco (yellow catfish, species) [taxon 1234273], Penaeus vannamei (Pacific white shrimp, species) [taxon 6689], Actinopterygii (fishes, superclass) [taxon 7898], Arachis hypogaea (goober, species) [taxon 3818], Actinomycetota (actinobacteria, phylum) [taxon 201174], Oreochromis mossambicus (Hawaiian perch, species) [taxon 8127], Channa argus (northern snakehead, species) [taxon 215402], gut metagenome (species) [taxon 749906], Armatimonadota (phylum) [taxon 67819]

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961228/full.md

---
Source: https://tomesphere.com/paper/PMC12961228